The Discovery
MNTF and the role it plays in Human Fetus Development

Learn about GM600
The peptide with neurotrophic properties

Programs for Stroke and
other Neural Diseases

Clinical Pipeline
There are 12 Phase 2 ready clinical trials in the pipeline.

News & Press Releases
New class of CNS master regulator peptide drugs

Interviews by Visiongain and CEOCFO

ALS MOA Presentation
Regulate over 30 ALS genes through 8 pathways

Muti-target Peptide Drugs
Endogenous embryonic stage master regulator drugs

On-going Clinical Trials
ALS, Stroke, and Parkinson's Disease Clinical Trials

Trial Science/Data
Top Line Summary of Multiple Statistical Significance in Preclinical Trials and in Clinical Trials Result

Copyright © 2017 Genervon Biopharmaceuticals, LLC. All rights reserved. All other trademarks or trade names are the property of their respective holders.